A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The objective of this Phase 2 study is to assess the safety and efficacy of single treatment of trenibotulinumtoxinE and onabotulibumtoxinA combination in adult participants with moderate to severe upper facial lines. The study has two parts; Part 1 evaluates treatment for glabellar lines.
Epistemonikos ID: e4a5c5c9b42d302e68d0d52779790280bf4c8270
First added on: Oct 14, 2026